
Explore patient-derived tumoroids as cost-effective cancer immunotherapy research models and learn about a proof-of-concept screening platform for validating NK cell cytotoxic activity.

Explore advanced CAR T-cell therapy strategies for solid tumors, focusing on lateral architectures to overcome efficacy challenges in non-hematological cancers.

Explore early detection methods for epithelial ovarian cancer, addressing diagnostic challenges and the potential role of biomarkers in improving patient outcomes and resource allocation.

Explore single-cell ATAC-seq techniques to identify open chromatin regions and understand gene expression regulation in individual cancer cells for advancing precision medicine.

Explore tumor markers' role in cancer screening and surveillance. Learn about their types, clinical applications, and considerations for implementation in medical practice.

Explore free light chain assays for evaluating MGUS in clinical practice. Learn about their importance in monitoring precursor conditions to Multiple Myeloma and AL Amyloidosis.

Explore the role of tertiary lymphoid structures in tumor immunity, their correlation with improved prognosis, and their impact on immunotherapy response through in-depth spatial imaging analysis.

Explore variability in monoclonal gammopathy testing, focusing on Free Light Chain use for detection. Learn from expert Dr. Keren about challenges and advancements in this critical diagnostic field.

Explore COVID-19 immunity assessment in cancer patients from Alpha to Omicron variants. Gain insights from oncology expert Dr. Balazs Halmos on translational research and clinical implications.

Explore genomic testing's role in prostate cancer management. Learn about molecular drivers, genetic testing rationale, and how to incorporate this knowledge into urological practice.

Explore innovative CAR NK cell therapy for ovarian cancer using non-viral transposon engineering and CRISPR/Cas9 editing. Learn about advancements in immunotherapy and potential applications in solid tumors.

Explore measurable residual disease (MRD) in solid tumors and hematological indications, its clinical applications, and future developments in cancer treatment and monitoring.

Explore current challenges in early-stage cancer care, focusing on biomarker assessment and rapid access to optimal treatment. Learn about improving patient outcomes and reducing financial burdens.

Explore the evolution of prostate cancer surgery through insights from 17,000 robotic-assisted laparoscopic prostatectomies. Gain valuable lessons on surgical advancements and improved patient outcomes.

Explore the link between neurodevelopment and cancer biology, focusing on neurotrophins and their receptors. Gain insights into CNS tumor growth and potential novel therapeutic approaches.

Explore CAR T cell monitoring techniques for successful treatment outcomes. Learn about critical reagents, detection strategies, and flow cytometry assays from expert researchers.

Explore solutions to advance CAR NK cell and Treg-based therapies from research to clinical applications. Discover products, tools, and services to move your projects forward.

Explore novel cancer immunotherapies using B cell epitope peptide vaccines, focusing on PD-L1 and HER-2 inhibitors for improved efficacy and reduced toxicity in clinical applications.

Explore a novel multiplexed test for detecting, predicting, and monitoring bladder cancer. Learn about hematuria evaluation and advancements in bladder cancer diagnostics from an expert physician-scientist.

Explore techniques for enriching antigen-specific T-cells through selective depletion of CD45RA expressing cells, enhancing immunotherapy potential for virus-associated malignancies.

Explore genomic biomarkers for predicting breast cancer treatment response. Learn about research approaches, AI applications, and translational programs to improve patient outcomes.